fig2
From: Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML
Figure 2. Exosomal miR-92b-5p is related to doxorubicin resistance in AML patients and cell lines. (A) The expression of exosomal miR-92b-5p in AML patients; (B) The expression of exosomal miR-92b-5p in K562 and K562/DOX cells; (C) The expression of miR-92b-5p in K562 and K562/DOX cells; (D) The IC50 value of doxorubicin in K562 and K562/DOX cells. *P < 0.05, **P < 0.01, ****P < 0.0001, n = 3. AML: Acute myeloid leukemia.
